Chinese authorities sought to reassure companies and jittery investors on Tuesday as a two-phase lockdown of Shanghai's 26 million people entered its second day, casting an unusual quiet over the normally bustling center ...
Mar 29, 2022
0
3
A new coronavirus variant identified in southern Africa is leading to a new round of travel restrictions just as many had finally begun to ease.
Nov 26, 2021
0
4
An extra 267,000 infants will likely have died in 2020 in low and middle income countries as a result of the economic downturn caused by COVID-19, finds a modeling study, published in the online journal BMJ Open.
Aug 23, 2021
0
569
The WHO on Thursday urged China to share raw data from the earliest COVID-19 cases to revive the pandemic origins probe—and release information to address the controversial lab leak theory.
Aug 12, 2021
0
4
The European Union said Wednesday that it is expecting 50 million Pfizer coronavirus vaccine doses earlier than expected, as the United States said it would continue a pause in vaccinations using the Johnson & Johnson shot ...
Apr 15, 2021
0
2
Two Chinese coronavirus jabs are safe and effective, WHO experts said Wednesday after reviewing partial data, providing a potential boost to countries from Australia to Europe struggling to roll out vaccines fast enough.
Mar 31, 2021
0
1
An international expert team that visited China to investigate the origins of COVID-19 has postponed publishing their report, which will now likely appear next week, the WHO said Tuesday.
Mar 16, 2021
0
6
The much-anticipated report from the international mission to Wuhan to investigate COVID-19's origins is set to be published this week, following intense US and Chinese pressure over its contents.
Mar 15, 2021
0
5
Several countries suspended the use of AstraZeneca's vaccine on Thursday over blood clot fears, prompting Europe's medical agency to quickly reassure the public there were no known health risks linked to the jab.
Mar 11, 2021
1
30
The World Trade Organization faces calls led by India and South Africa to waive intellectual property rights for COVID-19 vaccines—a notion fiercely rejected by pharmaceutical giants and their host countries.
Mar 1, 2021
0
2
